mardi 13 novembre 2018

Onco Actu du 13 novembre 2018

1.4 Biologie - Technos

Engineering Biology, For Real? [In the Pipeline]

2.7 Etiologie - Obésité

Scientists shine new light on link between obesity and cancer [Trinity College]

Fat-clogged cells explain why obesity can cause cancer [BBC News]

3.3 Prévention - Vaccins

Australia is about to eradicate cervical cancer, US is nowhere close. What'll it take? [USA Today]

4.12 Biopsies liquides

A $3 Billion Startup's Shares Gain On Hopes For A Cancer Blood Test [Forbes]

4.3 Dép., diag. & prono. - Industriels

Artificial intelligence decodes cancer pathology images [Novartis]

4.9 Dép., diag. & prono. - Sein

Latest European Commission Initiative on Breast Cancer Recommendations [ESMO]

5.10 Traitements - Essais

France Begins Speeding Clinical Trial Start-Up Times [RAPS]

5.12 Immunothérapies

Fecal Transplant Heals Colitis Caused by Immunotherapy [The Scientist]

In a paradox, obesity is a ‘net positive’ for cutting-edge anticancer drugs [Science]

5.12.5 Immunothérapies - Pharma

FDA grants priority review to Roche’s Tecentriq in combination with Abraxane for the initial treatment of people with PD-L1-positive, metastatic triple-negative breast cancer [Roche]

5.12.6 Immunothérapies - AMM

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib [Merck]

Merck suits up for another Opdivo showdown with Keytruda liver cancer approval [FiercePharma]

MSD’s Keytruda approved for liver cancer [PharmaTimes]

FDA Opens Door to New Response Criteria for Cancer Immunotherapies [BioCentury]

5.12.7 Immunothérapies - vaccins

Boehringer backs $33M cancer vaccine play at Switzerland’s AMAL Therapeutics [EndPoints]

5.12.9 Immunothérapies - SITC

SITC 2018 Scientific Highlights - Nov. 11 [SITC]

5.2 Pharma

AstraZeneca, Merck's Lynparza scores speedy review in blockbuster ovarian cancer market [FiercePharma]

The top 10 cancer drug makers of 2024 [FiercePharma]

6. Lutte contre les cancers

In China, Desperate Patients Smuggle Drugs. Or Make Their Own. [NY Times]

6.10 Politiques

The Prime Minister committed to diagnosing cancers earlier – so how many staff does the NHS need to get there? [Cancer Research UK]

6.6 Publications

Arguments over European open-access plan heat up [Nature]

6.7.2 Applis

‘We ran out of money’: High-profile startup seeking to connect patients with clinical trials shuts down [STAT]